First case of rare blood-clotting condition linked to J&J COVID-19 vaccine diagnosed in Utah –

SALT LAKE CITY– The first case of an uncommon blood-clotting condition believed to be linked to the Johnson & & Johnson COVID-19 vaccine has been detected in Utah.A male patient was just recently identified with vaccine-induced Thrombotic Thrombocytopenia, also known as VITT, at the University of Utah Hospital, U. health officials stated in a Wednesday news release.The client was treated and is now recuperating at home, according to the release. Health officials didnt supply any more information about the case in the release. A news conference is scheduled for 2:30 p.m. Wednesday where physicians are expected to additional go over the case.The embolism condition caused a nationwide time out on administration of the Johnson & & Johnson vaccine last month after six cases were reported amongst over 6 million individuals who got the vaccine. The time out was raised on April 23 after federal regulators identified the vaccines continued usage was safe.This story will be updated. × More stories you might have an interest in